Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy
- PMID: 23953407
- DOI: 10.1016/j.radonc.2013.06.043
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy
Abstract
Background and purpose: Modern radiotherapy (RT) techniques such as stereotactic RT, intensity-modulated RT, or particle irradiation allow local dose escalation with simultaneous sparing of critical organs. Several trials are currently investigating their benefit in glioma reirradiation and boost irradiation. Target volume definition is of critical importance especially when steep dose gradient techniques are employed. In this manuscript we investigate the impact of O-(2-(F-18)fluoroethyl)-l-tyrosine-positron emission tomography/computer tomography (FET-PET/CT) on target volume definition in low and high grade glioma patients undergoing either first or re-irradiation with particles.
Methods and material: We investigated volumetric size and uniformity of magnetic resonance imaging (MRI)- vs. FET-PET/CT-derived gross tumor volumes (GTVs) and planning target volumes (PTVs) of 41 glioma patients. Clinical cases are presented to demonstrate potential benefits of integrating FET-PET/CT-planning into daily routine.
Results: Integrating FET-uptake into the delineation of GTVs yields larger volumes. Combined modality-derived PTVs are significantly enlarged in high grade glioma patients and in case of primary RT. The congruence of MRI and FET signals for the identification of glioma GTVs is poor with mean uniformity indices of 0.39. MRI-based PTVs miss 17% of FET-PET/CT-based GTVs. Non significant alterations were detected in low grade glioma patients and in those undergoing reirradiation.
Conclusions: Target volume definition for malignant gliomas during initial RT may yield significantly differing results depending upon the imaging modality, which the contouring process is based upon. The integration of both MRI and FET-PET/CT may help to improve GTV coverage by avoiding larger incongruences between physical and biological imaging techniques. In low grade gliomas and in cases of reirradiation, more studies are needed in order to investigate a potential benefit of FET-PET/CT for planning of RT.
Keywords: Boost irradiation; Delineation; FET; Glioma; Uniformity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
FET-PET for malignant glioma treatment planning.Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093
-
Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.J Med Imaging Radiat Oncol. 2018 Feb;62(1):122-127. doi: 10.1111/1754-9485.12676. Epub 2017 Oct 5. J Med Imaging Radiat Oncol. 2018. PMID: 28980392
-
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1100-6. doi: 10.1016/j.ijrobp.2013.09.008. Epub 2013 Oct 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 24161427
-
Positron emission tomography for radiation treatment planning.Strahlenther Onkol. 2005 Aug;181(8):483-99. doi: 10.1007/s00066-005-1422-7. Strahlenther Onkol. 2005. PMID: 16044216 Review.
-
Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.Chin J Cancer. 2014 Jan;33(1):16-24. doi: 10.5732/cjc.013.10217. Chin J Cancer. 2014. PMID: 24384237 Free PMC article. Review.
Cited by
-
Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.J Neurooncol. 2015 May;122(3):559-66. doi: 10.1007/s11060-015-1745-x. Epub 2015 Feb 22. J Neurooncol. 2015. PMID: 25702193
-
[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.BMJ Open. 2023 Aug 4;13(8):e071327. doi: 10.1136/bmjopen-2022-071327. BMJ Open. 2023. PMID: 37541751 Free PMC article.
-
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.Sci Rep. 2018 May 8;8(1):7201. doi: 10.1038/s41598-018-25350-7. Sci Rep. 2018. PMID: 29740097 Free PMC article.
-
Relationship between Glioblastoma Dose Volume Parameters Measured by Dual Time Point Fluoroethylthyrosine-PET and Clinical Outcomes.Front Neurol. 2018 Jan 22;8:756. doi: 10.3389/fneur.2017.00756. eCollection 2017. Front Neurol. 2018. PMID: 29403428 Free PMC article.
-
Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methods.Eur Radiol. 2019 Aug;29(8):4276-4285. doi: 10.1007/s00330-018-5942-9. Epub 2019 Jan 11. Eur Radiol. 2019. PMID: 30635757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical